It is the expectation of the editors that this volume will become a gold standard book -- the only singular source of current and cutting-edge information for all those working with drug abusing or addicted patients or for those interested in this topic from other research perspectives. In brief, Drug Abuse and Addiction in Medical Illness: Causes, Consequences, and Treatment, will contain 62 chapters covering drugs of abuse and how they play a role in a wide range of medical illnesses. That is, the volume will discuss how, for some diseases, drug abuse will cause or enhance the progress of…mehr
It is the expectation of the editors that this volume will become a gold standard book -- the only singular source of current and cutting-edge information for all those working with drug abusing or addicted patients or for those interested in this topic from other research perspectives. In brief, Drug Abuse and Addiction in Medical Illness: Causes, Consequences, and Treatment, will contain 62 chapters covering drugs of abuse and how they play a role in a wide range of medical illnesses. That is, the volume will discuss how, for some diseases, drug abuse will cause or enhance the progress of that disease/disorder, while other diseases may result in or enhance drug abuse. The chapters in that section will thus deal with this crucial, bi-directional relationship. Leading experts in the field of addiction throughout the world will contribute to the volume. This means the designed content will cover virtually every core, as well as contemporary, topic in the subject area, from the established theories to the most modern research and development in the field of drug abuse and addiction. Thus, once completed, the volume will be a first of its kind book, rich yet comprehensive and focused (specifically to the designated area), and will address the needs of the very active theoretical, basic, and clinical research in the field.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
INTRODUCTION [The chapters in this section will give a general overview of the causes, vulnerability and risk factors for drug abuse and addiction]1. Drug abuse, dependence and addiction Koob GF Department of Neuropharmacology, CVN-7, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. gkoob@scripps.edu 2. Epidemiology and trends in drug abuse McCambridge J National Addiction Centre, Institute of Psychiatry, King's College London, London, UK. J.McCambridge@iop.kcl.ac.uk 3. Brain reward system and compulsive drug use Kenny PJ Department of Biochemistry, The Scripps Research Institute, Jupiter, FL 33458, USA. pjkenny@scripps.edu 4. Genetic vulnerability for Drug Abuse and Addiction G Uhl Molecular Neurobiology Branch, National Institute on Drug Abuse-Intramural Research Program, National Institutes of Health, Baltimore, Maryland, USA. guhl@intra.nida.nih.gov 5. Adolescent brain development and vulnerability for addiction Crews F Bowles Center for Alcohol Studies, School of Medecine, University of North Carolina at Chapel Hill, NC 27599, USA. ftcrews@med.unc.edu 6. Personality risk factors for drug abuse and addiction Conrod PJ Department of Psychological Medicine and Psychiatry, Section of Addiction, King's College London, University of London, London, UK. p.conrod@iop.kcl.ac.uk 7. Automatic and controlled processes in the pathway from drug abuse to addiction Wiers R Experimental Psychology, Maastricht University, Maastricht, The Netherlands. r.wiers@psychology.unimaas.nl 8. Pharmacological treatment of drug abuse and addiction in medical illness Tiet QQ Center for Health Care Evaluation, VA Palo Alto Health Care System, Palo Alto, California 94025, USA. Tietq2@yahoo.com 9. Psychological interventions for drug abuse and addiction Brunette MF Department of Psychiatry, Dartmouth Medical School, Hanover, NH 03301, USA. maryfbrunette@dartmouth.edu 10. Drug abuse and addiction in adolescents Deas D Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC 29417, USA. deasd@musc.edu 11. Drug abuse and addiction in elderly Simoni-Wastila L Long-term Care Initiative, Peter Lamy Center on Drug Therapy and Aging, School of Pharmacy, University of Maryland Baltimore, Baltimore, Maryland 21201, USA. lsimoniw@rx.umaryland.edu DRUGS OF ABUSE AND ADDICTION [The following chapters are intended to describe generally the mechanism of action, use and abuse of these drugs, consequences (daily life, cognitive performance), and the relationship between their use and medical illness]12. Alcohol Sher KJ Department of Psychological Sciences, University of Missouri-Columbia, Columbia, MO 65211, USA. sherk@missouri.edu 13. Nicotine Mucha L Pharmaceutical Outcomes Research, Thomson Medstat, 150 Cambridge Park Drive, Cambridge, MA 02140, USA. Lisa.mucha@thomson.com 14. Cannabis Di Forti M Division of Psychological Medicine, Institute of Psychiatry, London, UK. m.diforti@iop.kcl.ac.uk 15. Cocaine Kalivas PW Department of Neurosciences, Medical University of South Carolina. Charleston, South Carolina 29425, USA. kalivasp@musc.edu 16. Ecstasy and LSD Nichols DE Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, IN 47907-2091, USA. david.e.nichols.l@purdue.edu 17. Methamphetamine Barr AL Centre for Complex Disorders, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada. albarr@interchange.ubc.ca 18. GHB Anderson IB California Poison Control System, Department of Clinical Pharmacy, University of California, San Francisco, CA, USA. iba@calpoison.org 19. Herbal drugs of abuse Richardson WH, Department of Emergency Medicine, Palmetto Health Richland, 3 Medical Park, Columbia, SC 29203, USA. whrichardson@sc.rr.com 20. Inhalants Wu LT Center for Risk Behavior and Mental Health Research, RTI International,
INTRODUCTION [The chapters in this section will give a general overview of the causes, vulnerability and risk factors for drug abuse and addiction]1. Drug abuse, dependence and addiction Koob GF Department of Neuropharmacology, CVN-7, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. gkoob@scripps.edu 2. Epidemiology and trends in drug abuse McCambridge J National Addiction Centre, Institute of Psychiatry, King's College London, London, UK. J.McCambridge@iop.kcl.ac.uk 3. Brain reward system and compulsive drug use Kenny PJ Department of Biochemistry, The Scripps Research Institute, Jupiter, FL 33458, USA. pjkenny@scripps.edu 4. Genetic vulnerability for Drug Abuse and Addiction G Uhl Molecular Neurobiology Branch, National Institute on Drug Abuse-Intramural Research Program, National Institutes of Health, Baltimore, Maryland, USA. guhl@intra.nida.nih.gov 5. Adolescent brain development and vulnerability for addiction Crews F Bowles Center for Alcohol Studies, School of Medecine, University of North Carolina at Chapel Hill, NC 27599, USA. ftcrews@med.unc.edu 6. Personality risk factors for drug abuse and addiction Conrod PJ Department of Psychological Medicine and Psychiatry, Section of Addiction, King's College London, University of London, London, UK. p.conrod@iop.kcl.ac.uk 7. Automatic and controlled processes in the pathway from drug abuse to addiction Wiers R Experimental Psychology, Maastricht University, Maastricht, The Netherlands. r.wiers@psychology.unimaas.nl 8. Pharmacological treatment of drug abuse and addiction in medical illness Tiet QQ Center for Health Care Evaluation, VA Palo Alto Health Care System, Palo Alto, California 94025, USA. Tietq2@yahoo.com 9. Psychological interventions for drug abuse and addiction Brunette MF Department of Psychiatry, Dartmouth Medical School, Hanover, NH 03301, USA. maryfbrunette@dartmouth.edu 10. Drug abuse and addiction in adolescents Deas D Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC 29417, USA. deasd@musc.edu 11. Drug abuse and addiction in elderly Simoni-Wastila L Long-term Care Initiative, Peter Lamy Center on Drug Therapy and Aging, School of Pharmacy, University of Maryland Baltimore, Baltimore, Maryland 21201, USA. lsimoniw@rx.umaryland.edu DRUGS OF ABUSE AND ADDICTION [The following chapters are intended to describe generally the mechanism of action, use and abuse of these drugs, consequences (daily life, cognitive performance), and the relationship between their use and medical illness]12. Alcohol Sher KJ Department of Psychological Sciences, University of Missouri-Columbia, Columbia, MO 65211, USA. sherk@missouri.edu 13. Nicotine Mucha L Pharmaceutical Outcomes Research, Thomson Medstat, 150 Cambridge Park Drive, Cambridge, MA 02140, USA. Lisa.mucha@thomson.com 14. Cannabis Di Forti M Division of Psychological Medicine, Institute of Psychiatry, London, UK. m.diforti@iop.kcl.ac.uk 15. Cocaine Kalivas PW Department of Neurosciences, Medical University of South Carolina. Charleston, South Carolina 29425, USA. kalivasp@musc.edu 16. Ecstasy and LSD Nichols DE Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, IN 47907-2091, USA. david.e.nichols.l@purdue.edu 17. Methamphetamine Barr AL Centre for Complex Disorders, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada. albarr@interchange.ubc.ca 18. GHB Anderson IB California Poison Control System, Department of Clinical Pharmacy, University of California, San Francisco, CA, USA. iba@calpoison.org 19. Herbal drugs of abuse Richardson WH, Department of Emergency Medicine, Palmetto Health Richland, 3 Medical Park, Columbia, SC 29203, USA. whrichardson@sc.rr.com 20. Inhalants Wu LT Center for Risk Behavior and Mental Health Research, RTI International,
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
